The KCNE genes in hypertrophic cardiomyopathy: A candidate gene study

Journal of Negative Results in BioMedicine

Volumn 10, Issue 1, 2011, Pages

  Hedley, Paula L ^a,b   Haundrup, Ole ^c   Andersen, Paal S ^a   Aidt, Frederik H ^a   Jensen, Morten ^d   Moolman Smook, Johanna C ^b   Bundgaard, Henning ^d   Christiansen, Michael ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c ROSKILDE HOSPITAL   (Denmark)

^d University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNE3; POTASSIUM CHANNEL KCNE4; POTASSIUM CHANNEL KCNE5; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; KCNE1 PROTEIN, HUMAN; KCNE1L PROTEIN, HUMAN; KCNE2 PROTEIN, HUMAN; KCNE3 PROTEIN, HUMAN; KCNE4 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; COHORT ANALYSIS; GENETICS; MIDDLE AGED; MUTATION;

3' UNTRANSLATED REGIONS; CARDIOMYOPATHY, HYPERTROPHIC; COHORT STUDIES; FEMALE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; MUTATION; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 80053456148     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-10-12     Document Type: Article

References (42)

1. Hypertrophic Cardiomyopathy. Behr ER, McKenna WJ, Curr Treat Options Cardiovasc Med 2002 4 6 443 453 10.1007/s11936-002-0039-8 12408787
2. Hypertrophic cardiomyopathy: a systematic review. Maron BJ, JAMA 2002 287 10 1308 1320 10.1001/jama.287.10.1308 11886323 (Pubitemid 34250486)
3. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Andersen PS, Havndrup O, Hougs L, Sorensen KM, Jensen M, Larsen LA, Hedley P, Thomsen AR, Moolman-Smook J, Christiansen M, et al. Hum Mutat 2009 30 3 363 370 10.1002/humu.20862 19035361
4. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. McNair WP, Ku L, Taylor MR, Fain PR, Dao D, Wolfel E, Mestroni L, Circulation 2004 110 15 2163 2167 10.1161/01.CIR.0000144458.58660.BB 15466643 (Pubitemid 39372495)
5. Dilated cardiomyopathy is associated with reduced expression of the cardiac sodium channel Scn5a. Hesse M, Kondo CS, Clark RB, Su L, Allen FL, Geary-Joo CT, Kunnathu S, Severson DL, Nygren A, Giles WR, et al. Cardiovasc Res 2007 75 3 498 509 10.1016/j.cardiores.2007.04.009 17512504 (Pubitemid 47082512)
6. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Bienengraeber M, Olson TM, Selivanov VA, Kathmann EC, O'Cochlain F, Gao F, Karger AB, Ballew JD, Hodgson DM, Zingman LV, et al. Nat Genet 2004 36 4 382 387 10.1038/ng1329 15034580 (Pubitemid 38437261)
7. Potassium channel subunits encoded by the KCNE gene family: physiology and pathophysiology of the MinK-related peptides (MiRPs). Abbott GW, Goldstein SA, Mol Interv 2001 1 2 95 107 14993329
8. KCNE5 induces time- and voltage-dependent modulation of the KCNQ1 current. Angelo K, Jespersen T, Grunnet M, Nielsen MS, Klaerke DA, Olesen SP, Biophys J 2002 83 4 1997 2006 10.1016/S0006-3495(02)73961-1 12324418
9. KCNE4 is an inhibitory subunit to the KCNQ1 channel. Grunnet M, Jespersen T, Rasmussen HB, Ljungstrom T, Jorgensen NK, Olesen SP, Klaerke DA, J Physiol 2002 542 Pt 1 119 130 12096056 (Pubitemid 35203234)
10. KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels. Grunnet M, Rasmussen HB, Hay-Schmidt A, Rosenstierne M, Klaerke DA, Olesen SP, Jespersen T, Biophys J 2003 85 3 1525 1537 10.1016/S0006-3495(03)74585-8 12944270 (Pubitemid 37052239)
11. KCNE3 is an inhibitory subunit of the Kv4.3 potassium channel. Lundby A, Olesen SP, Biochem Biophys Res Commun 2006 346 3 958 967 10.1016/j.bbrc.2006.06. 004 16782062
12. KCNE1 binds to the KCNQ1 pore to regulate potassium channel activity. Melman YF, Um SY, Krumerman A, Kagan A, McDonald TV, Neuron 2004 42 6 927 937 10.1016/j.neuron.2004.06.001 15207237 (Pubitemid 38798231)
13. MinK-dependent internalization of the IKs potassium channel. Xu X, Kanda VA, Choi E, Panaghie G, Roepke TK, Gaeta SA, Christini DJ, Lerner DJ, Abbott GW, Cardiovasc Res 2009 82 3 430 438 19202166
14. Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome. Bianchi L, Shen Z, Dennis AT, Priori SG, Napolitano C, Ronchetti E, Bryskin R, Schwartz PJ, Brown AM, Hum Mol Genet 1999 8 8 1499 1507 10.1093/hmg/8.8.1499 10400998 (Pubitemid 29374084)
15. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome. Duggal P, Vesely MR, Wattanasirichaigoon D, Villafane J, Kaushik V, Beggs AH, Circulation 1998 97 2 142 146 9445165 (Pubitemid 28124670)
16. The genetic basis of Brugada syndrome: a mutation update. Hedley PL, Jorgensen P, Schlamowitz S, Moolman-Smook J, Kanters JK, Corfield VA, Christiansen M, Hum Mutat 2009 30 9 1256 1266 10.1002/humu.21066 19606473
17. The genetic basis of long QT and short QT syndromes: a mutation update. Hedley PL, Jorgensen P, Schlamowitz S, Wangari R, Moolman-Smook J, Brink PA, Kanters JK, Corfield VA, Christiansen M, Hum Mutat 2009 30 11 1486 1511 10.1002/humu.21106 19862833
18. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt P, Smeets HJ, Schulze-Bahr E, Haverkamp W, Breithardt G, Cohen N, et al. J Mol Med 2004 82 3 182 188 10.1007/s00109-003-0522-z 14760488 (Pubitemid 38392168)
19. Spectrum of mutations in long-QT syndrome genes. Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, et al. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000 102 10 1178 1185
20. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Yang Y, Xia M, Jin Q, Bendahhou S, Shi J, Chen Y, Liang B, Lin J, Liu Y, Liu B, et al. Am J Hum Genet 2004 75 5 899 905 10.1086/425342 15368194 (Pubitemid 39390498)
21. Functional Effects of KCNE3 Mutation and its Role in the Development of Brugada Syndrome. Delpon E, Cordeiro JM, Nunez L, Thomsen PE, Guerchicoff A, Pollevick GD, Wu Y, Kanters JK, Larsen CT, Burashnikov E, et al. Circ Arrhythm Electrophysiol 2008 1 3 209 218 10.1161/CIRCEP.107.748103 19122847
22. Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation. Ravn LS, Aizawa Y, Pollevick GD, Hofman-Bang J, Cordeiro JM, Dixen U, Jensen G, Wu Y, Burashnikov E, Haunso S, et al. Heart Rhythm 2008 5 3 427 435 10.1016/j.hrthm.2007.12.019 18313602
23. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Abbott GW, Butler MH, Bendahhou S, Dalakas MC, Ptacek LJ, Goldstein SA, Cell 2001 104 2 217 231 10.1016/S0092-8674(01) 00207-0 11207363 (Pubitemid 32174838)
24. Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f). Roepke TK, Kontogeorgis A, Ovanez C, Xu X, Young JB, Purtell K, Goldstein PA, Christini DJ, Peters NS, Akar FG, et al. FASEB J 2008 22 10 3648 3660 10.1096/fj.08-110171 18603586
25. Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis. Roepke TK, King EC, Reyna-Neyra A, Paroder M, Purtell K, Koba W, Fine E, Lerner DJ, Carrasco N, Abbott GW, Nat Med 2009 15 10 1186 1194 10.1038/nm.2029 19767733
26. Targeted deletion of Kcne2 causes gastritis cystica profunda and gastric neoplasia. Roepke TK, Purtell K, King EC, La Perle KM, Lerner DJ, Abbott GW, PLoS One 2010 5 7 11451 10.1371/journal.pone.0011451 20625512
27. Expression of multiple KCNE genes in human heart may enable variable modulation of I(Ks). Lundquist AL, Manderfield LJ, Vanoye CG, Rogers CS, Donahue BS, Chang PA, Drinkwater DC, Murray KT, George AL Jr, J Mol Cell Cardiol 2005 38 2 277 287 10.1016/j.yjmcc.2004.11.012 15698834 (Pubitemid 40215197)
28. Disease-associated mutations in KCNE potassium channel subunits (MiRPs) reveal promiscuous disruption of multiple currents and conservation of mechanism. Abbott GW, Goldstein SA, FASEB J 2002 16 3 390 400 10.1096/fj.01-0520hyp 11874988 (Pubitemid 34195300)
29. Specific interaction of the potassium channel beta-subunit minK with the sarcomeric protein T-cap suggests a T-tubule-myofibril linking system. Furukawa T, Ono Y, Tsuchiya H, Katayama Y, Bang ML, Labeit D, Labeit S, Inagaki N, Gregorio CC, J Mol Biol 2001 313 4 775 784 10.1006/jmbi.2001.5053 11697903 (Pubitemid 33063426)
30. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Bos JM, Poley RN, Ny M, Tester DJ, Xu X, Vatta M, Towbin JA, Gersh BJ, Ommen SR, Ackerman MJ, Mol Genet Metab 2006 88 1 78 85 10.1016/j.ymgme.2005. 10.008 16352453
31. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Knoll R, Hoshijima M, Hoffman HM, Person V, Lorenzen-Schmidt I, Bang ML, Hayashi T, Shiga N, Yasukawa H, Schaper W, et al. Cell 2002 111 7 943 955 10.1016/S0092-8674(02) 01226-6 12507422 (Pubitemid 36044687)
32. Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing hearts. Radicke S, Cotella D, Graf EM, Banse U, Jost N, Varro A, Tseng GN, Ravens U, Wettwer E, Cardiovasc Res 2006 71 4 695 703 10.1016/j.cardiores.2006.06.017 16876774 (Pubitemid 44848011)
33. Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation. Jurkat-Rott K, Lehmann-Horn F, Neurology 2004 62 6 1012 1015 15037716 (Pubitemid 38435802)
34. Arrhythmia in hypertrophic cardiomyopathy. McKenna WJ, England D, Doi YL, Deanfield JE, Oakley C, Goodwin JF, I: Influence on prognosis Br Heart J 1981 46 2 168 172
35. The contribution of genes involved in potassium-recycling in the inner ear to noise-induced hearing loss. Van Laer L, Carlsson PI, Ottschytsch N, Bondeson ML, Konings A, Vandevelde A, Dieltjens N, Fransen E, Snyders D, Borg E, et al. Hum Mutat 2006 27 8 786 795 10.1002/humu.20360 16823764 (Pubitemid 44205072)
36. Compound mutations: a common cause of severe long-QT syndrome. Westenskow P, Splawski I, Timothy KW, Keating MT, Sanguinetti MC, Circulation 2004 109 15 1834 1841 10.1161/01.CIR.0000125524.34234.13 15051636 (Pubitemid 38509116)
37. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, et al. Circulation 1996 93 5 841 842 8598070 (Pubitemid 26074816)
38. Prevalence of dignostic abnormalities in patients with genetically transmitted asymmetric septal hypertrophy. ten Cate FJ, Hugenholtz PG, van Dorp WG, Roelandt J, Am J Cardiol 1979 43 4 731 737 10.1016/0002-9149(79)90071-7 570800 (Pubitemid 9150825)
39. Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PE, Hum Mutat 2008 29 1 6 13 10.1002/humu.20654 18000842
40. Atrial fibrillation-associated minK38G/S polymorphism modulates delayed rectifier current and membrane localization. Ehrlich JR, Zicha S, Coutu P, Hebert TE, Nattel S, Cardiovasc Res 2005 67 3 520 528 10.1016/j.cardiores.2005. 03.007 16039273 (Pubitemid 41019559)
41. A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. Dias Da Silva MR, Cerutti JM, Arnaldi LA, Maciel RM, J Clin Endocrinol Metab 2002 87 11 4881 4884 10.1210/jc.2002-020698 12414843 (Pubitemid 35316320)
42. Does KCNE5 play a role in long QT syndrome? Hofman-Bang J, Jespersen T, Grunnet M, Larsen LA, Andersen PS, Kanters JK, Kjeldsen K, Christiansen M, Clin Chim Acta 2004 345 1-2 49 53 10.1016/j.cccn.2004.02.033 15193977 (Pubitemid 38749171)